chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dec 23 started having right side facial tingling, slight numbness, decreased sensation. Headache, fatigue. This facial symptoms came and went away daily in short intervals. On 12/27 I got dizzy, weakness, blurred vision, right face numbness, slight lip drooping, high blood pressure, trouble swallowing, tongue numbness on right side, and right arm tingling. Went to the doctor on 12/28 and got steroid treatment from being diagnosed with Bell?s palsy, and a ct scan that didn?t show anything abnormal.
On 8/15/14 one of or clinical nurses noted an extra MENVEO diluent in the box. 4 doses of this vaccine were given 8/14/14 by 3 different nurses and 8/15 the times of the vaccines were established and to  know the 4 clients who may have received the powder only. This client was one of the 4. No nurse working could be 100% sure that they gave the vaccine correctly using sterile diluent was one of diluent supplied. All 4 were notified by the supervisor who recommended re vaccination. Plans to blend vaccine and diluent are now in place - to double check vaccine before giving.
Symptoms started around 2:30 - 3:00 PM.  Throat swelling, eyes red and swollen, felt hot all over, eyes draining, lips swollen.  Took Benadryl about 7 PM and in AM 10/26.  Symptoms gone within 24 hrs.
Warm red rash on upper left arm where injection was received.  9 days after injection.  Arm slightly sore. Rash mostly gone within 48 hours.
Cellulitis developed at injection site, requiring ceftriaxone IM injections. Then oral cephalexin. Eventually resolved.
p/vax later arm began swelling, red & tender;tx in office;inflamed area measured 20x15inches;
None  The patient received the vaccination on 11/3/2020. There was no adverse outcome reported. It came to my attention on 1/22/2021 Friday  via email that a medication error had occurred.  I contacted the parent on 1/24/2021 and he reports no adverse reaction. We discussed patients weight, allergies, medications and any over the counter  supplement and I told him I will follow up as soon as I speak with the manufacturer  which was closed except Monday  to Friday Eastern Standard Time 8a to 5p.
feeling no good, no energy; Night sweat; taste of salt in mouth; trouble breathing; pain in arms; lost weight; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MALAISE (feeling no good, no energy), NIGHT SWEATS (Night sweat), DYSGEUSIA (taste of salt in mouth), DYSPNOEA (trouble breathing) and PAIN IN EXTREMITY (pain in arms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product INFLIXIMAB (INFLECTRA [INFLIXIMAB]) for Crohn's disease.    The patient's past medical history included Infection NOS. Concurrent medical conditions included Chronic disease and Inflammation (related to Crohn's ). Concomitant products included METRONIDAZOLE and CIPROFLOXACIN for Infection NOS.   On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient started INFLIXIMAB (INFLECTRA [INFLIXIMAB]) (unknown route) at an unspecified dose. On an unknown date, the patient experienced MALAISE (feeling no good, no energy), NIGHT SWEATS (Night sweat), DYSGEUSIA (taste of salt in mouth), DYSPNOEA (trouble breathing), PAIN IN EXTREMITY (pain in arms) and WEIGHT DECREASED (lost weight). At the time of the report, MALAISE (feeling no good, no energy), NIGHT SWEATS (Night sweat), DYSGEUSIA (taste of salt in mouth), DYSPNOEA (trouble breathing), PAIN IN EXTREMITY (pain in arms) and WEIGHT DECREASED (lost weight) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment for these events were not provided.
achy; Tired; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was tired and achy after the second dose of the Pfizer Covid-19 vaccine. The outcome of the events was unknown.   No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.
pt recvd vax & 22OCT92 following vax pt had elevated liver function tests (elevated liver enzymes) & elevated cholesterol (?);
administered every five years for 65 plus year olds; No adverse effect reported; Information has been received from a nurse via a company representative, referring to an unknown number of 65 plus years old patients(gender unknown). The patients' pertinent medical history, drug reactions/allergies, concurrent condition and concomitant medication were not provided.      On unknown dates, the patients were vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (once every 5 years; dose, route, batch/lot number and expiration date were not provided) for prophylaxis (inappropriate schedule of product administration). The reported called to get the price of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and stated it was very expensive especially since it was administered every five years for 65 plus year olds. No adverse effect was reported.
01/30/21: first dose. next day I got a big red spot where I was injected. I had a couple rashes across the top of it.  Body aches. Very Bad Fatigue. I would lay down for naps and I just could not get up and function. My temp was 1 degree higher but it wasn't a fever. Minimal Muscle Aches. 02/27/21: second dose. my arm did ache. I had some redness on the injection site. It went away. I also have a critical cervical disc and a disc spur that is pressing against my larynx. I felt very flushed from my neck up. I was uncomfortable and am planning on seeing my doctor.
PT VACCINATED USING PFIZER ON 4/27/21 (LOT EW0176) + 5/18/21 (LOT EW0186). S/O BEGAN 8/31/21, TESTED + 9/2/21
Nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
pt recvd vax; immed p/ MMR became pale,sat in chair,stiffened,became unresponsive,slumped to knees;incontinent of urine;episode lasted about 30 secs then alert & responsive;
Redenned swollen area, warm to touch of lower right arm just below injection site of Proquad.  "pre-cellutitis" per MD
Patient received two booster doses of Moderna one on 12/16/21 and the second on 2/23/22
Left arm with 5 cm x 4 cm redness and erythema at injection site of PCV23 site (left deltoid). Experiencing chills, night sweats, myalgias in legs, headache.
had vax & 2 wks later mom noted lump lt thigh @ inject site; lump inc in size & became purple in color; pt presented on 5APR94 w/ 1 1/34" fluctuant mass from which 3 cc purulent fluid was aspirated;
Briefly, is a 17-year-old female with no significant past medical history or family history with concerns for chest pain that began 12 hours after her second Covid 19 vaccine.  She said it began last night and was upper chest pain that radiated to her mouth.  She did have some mild chills at that time but no fevers.  It lasted for a couple of hours and now has since resolved after eating a sandwich and taking some Tylenol.  She had no shortness of breath or cough.  No palpitations or syncope.  No abdominal pain.  Had no clear exacerbating symptoms and no relationship to exertion.  No family history of cardiac concerns.            My examination revealed the patient to be active, alert, and in no distress. The HEENT exam was clear, the neck was supple, the lungs clear to auscultation, no crackles or wheeze, no increased work of breathing, no abnormal cardiac sounds, no murmur or gallop, no reproducible chest pain, the abdomen was nontender throughout, no hepatomegaly.  No lower extremity edema.            ED course: 17-year-old female with concerns for chest pain and chills 12 hours after receiving the second COVID-19 vaccine.  Now has complete resolution of her symptoms but seems primarily related to eating and Tylenol.  She has no other red flag symptoms such as exertional pain, palpitations, or syncope.  Has normal vital signs at this time with a normal examination.  Low concerns for vaccine induced myocarditis or other cardiac etiology but will obtain EKG.  More likely related to chills and possibly myalgias or could be some GERD related symptoms given it was resolved with food.  EKG grossly normal however does show possible T wave change in V3 that is possibly mildly elevated although this may not fully meet criteria.  Given this and her recent vaccine status will discuss with cardiology.  Cardiology felt this was benign early repolarization and no other acute concerns on EKG. Will followup with PCP and aware of signs and symptoms of when to return including recurrence of CP, SOB, syncope, or other concerns.             Patient safe for discharge to home. Discharged in improved condition. Written instructions reviewed with family.
Patient received KINRIX on Friday, 06/03/2016. Patient was later noted to have received PENTACEL on 10/15/2016. Since he was already years old at the time he received the PENTACEL, further doses of dtap and polio were not needed. Patient's guardian was called today (Monday,06/06/2016) and the error was reviewed. Patient's guardian reports patient had no adverse reactions or effects from the vaccines given that day.
Pt turned blue around mouth & hands trembling (not tonic-clonic) of chin & extremities; eyes rolled back into head several time for a few seconds @ a time; nl on exam 1/2 hr later;
I was diagnosed with Myeloma on March 15, 2023. My symptoms started on October 5, 2022 I experienced fatigue, occasional low grade fever, I was taking MOTRIN for my symptoms.
No abnormal outcomes for patient Noticed that the patient received a COVID Moderna Booster when due for COVID Moderna primary series dose 2
shoulder was sore right after the shot, which i believed to be normal. After a couple of weeks I was getting concerned, as my range of motion was not there without pain while working out or swimming. i have had to give up several arm exercises and overarm (crawl) swimming as a result of the pain. things that i have been doing for several years. I reached out to the Dr's office for an appointment and they said that there was nothing they could do for me and that i could report this myself. Please advise as to what i can do for this as it has been about 12 weeks and has not gotten any better.
This case was reported by a physician and described the occurrence of extensive swelling of vaccinated limb in a 69-year-old male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, several hours after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb, injection site erythema, injection site tenderness, myalgia, fatigue and headache. The patient was treated with paracetamol (Tylenol) and cetirizine hydrochloride (Zyrtec). On an unknown date, the outcome of the extensive swelling of vaccinated limb, injection site erythema, injection site tenderness, myalgia, fatigue and headache were recovered/resolved. It was unknown if the reporter considered the extensive swelling of vaccinated limb, injection site erythema, injection site tenderness, myalgia, fatigue and headache to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had no history of adverse reaction to other vaccines. The reporter was an allergist who tried to help a patient determine whether the patient should get the 2nd dose of SHINGRIX. The patient's major problem was large local reaction. The patient had symptoms of erythema, swelling and tenderness at the injection site for 10 days. The reaction started within a few hours and the size of the reaction continued to get larger and larger for 72 hours at which time it was 5 inches in diameter. The patient saw his internist at that point, he was told to take Tylenol and Zyrtec the erythema and swelling remained that 5 inch diameter size for 2 to 3 days and then slowly subsided over approximately 10 days. There was no sequelae. The patient also had symptoms of myalgias, fatigue and head ache for 2 days after the SHINGRIX injection. The patient realized that those symptoms were very common and was not concerned about them. The reporter asked the company if there was any experience with patients who had larger, longer lasting local reactions and subsequent administration of SHINGRIX likely to result in an even larger, longer lasting local reaction.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Mar2021 as dose 1, single (Lot number: ER8730), in left arm, on 20Apr2021 as dose 2, single (Lot number: EW0162), in left arm and on 17Nov2021 as dose 3 (booster), single (Lot number: FJ1620) at the age of 29 years, in left arm for covid-19 immunisation. The patient's had no relevant medical history. The patient did not have known allergies. Concomitant medication(s) included: ESTARYLLA, start date: 03Mar2019. The following information was reported: VACCINATION FAILURE (medically significant) with onset Jun2022, outcome "recovering", COVID-19 (medically significant) with onset Jun2022, outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2022) Positive. Therapeutic measures were taken as a result of covid-19.   Clinical course: From 27May2022 to 31May2022, the patient had Paxlovid for COVID-19. The adverse event symptoms dramatically improved on days 1 and 2 of taking Paxlovid. On day 6 onward, symptoms linger (head congestion, cough). Tested positive (faint positive) on at home test on day 6 and 7 after starting Paxlovid.  No follow-up attempts are possible. No further information is expected.
Thrombocytopenia with Platelet count of 2 with development of petechial rash and spontaneous bleeding from gums noted 3 days after immunization. Patient was evaluated in the Emergency Room and admitted to the hospital requiring IVIG infusion and IV steroids with slow up-trend in platelet count over 4 days of hospitalization prior to discharge with Platelet count of 49.
Soreness at the application arm; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included hypertension, diabetes and asthma.   On 25th November 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not reported. The patient's age could be 64 or 65 years of age. The patient was due to the second dose of Shingrix in May 2020 but this would likely be delayed due to the COVID-19 outbreak.  The pharmacist also mentioned that this patient experienced soreness at the application arm after dose one. Consented to follow up. This case is linked to the case US2020060868 and US2020060864 reported by the same reporter.
a fever of 100-101 degrees Fahrenheit from 28Apr2021 and ongoing; Cold; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received bnt162b2 (lot/batch number and expiration date not provided) via an unspecified route of administration in right arm last Tuesday on 27Apr2021 at 12:10 at the age of 52-year-old at 2nd dose, single for COVID-19 immunization(to be able to travel safely, as reported). Medical history was reported as none. The patient previously received bnt162b2 via an unspecified route of administration on 30Mar2021 at first dose, single for COVID-19 immunization. History of all previous immunization with the Pfizer vaccine considered as suspect, additional Vaccines Administered on Same Date of the Pfizer Suspect, Prior Vaccinations within 4 weeks, Family Medical History Relevant to AE(s), and Relevant Tests were all reported as none. Concomitant medications included multivitamin from 2019 and ongoing for maintaining health and estrogens (PREMPRO) at 0.3-1.5 mg, per tablet by mouth once daily from 2020 and ongoing for hormone replacement. The patient experienced a cold from 27Apr2021 and ongoing. It got worse but has since improved. The patient also had a fever from 28Apr2021 and ongoing. She still had a fever of 100-101 degrees Fahrenheit and she was asking if it is normal to have a fever for this long? If she takes excedrin or Ibuprofen the fever goes under 99 degrees. Otherwise it has gone up to a high of 101.3 degrees Fahrenheit. The outcome of fever was not recovered. The outcome of cold was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Started with a sore arm. Then the following Monday, I noticed a chest pain on my right side and shoulder blade.  Wednesday night I broke out in a rash and did zoom visit with Dr on Thursday and was diagnosed w/ shingles. They gave me Valtrex but it didn't help. Still itching with rash after a week, so they rx'd prednisone. Still having rash.
That afternoon felt pulling on left side down to left hip; next morning symptoms were painful from shoulder down to lower thigh felt pain and stiffness; from then moved to calf for 3 weeks then back up to thigh and shoulder. scale of 1-10, pain would be 8.  Around September tingling in fingers up to both shoulders and started feeling weakness in both arms; January getting worse-upper and lower body-heaviness in legs and arms. Can't sit for more than 15 minutes, when stand and try to walk lower body is very stiff in hip area, feel like lower body is locking up.  No strength in arms or legs too weak to pull self up if on floor doing stretches.  Had physical therapy for six weeks in December 2021 for L4-L5, no relief
Partial dose of vaccine (less than 1/2 dose) was given in error and repeat dose has been rescheduled per Guidelines.  Pt scheduled for revaccination 02/18/2021.  No adverse effects reported per RN.
The day after vaccination I was sleepy and the next day I felt normal. On the third day that I started to get the Migraines. It started on the left side. It was similar to my other migraines. It did not respond to my normal medication. I was nauseous but no aura. The Migraine lasted a week before I was headache free. I After the second dose of my vaccine I had the same pattern of Migraines for 5 or 6 days. I also had some head cold symptoms with the headaches after the second dose.
Woke up with very bad aches and chills, then developed swollen lymph nodes, heavy chest coughs, pain in adam's apple, loss of voice several times, infected saliva glands, sinus infection over several months. I still am suffering from issues and not completely back to full health and it is now February. I still am having some issues that won't go away.
vaccination failure; Covid 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Mar2021 as dose 1, single (Lot number: Er8732), in left arm, on 17Apr2021 as dose 2, single (Lot number: Ew0169), in left arm and on 22Sep2021 as dose 3 (booster), single (Lot number: Ew0187) at the age of 64 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "lymphoma" (unspecified if ongoing), notes: Cancer survivor (lymphoma). Concomitant medication(s) included: FLUOXETINE; OMEPRAZOLE. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "vaccination failure"; COVID-19 (medically significant), outcome "unknown", described as "Covid 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Rebound COVID - seemed worse than initial infection. Therapeutic measures were taken as a result of covid-19. Clinical Infomation: Patient took PAXLOVID as Covid 19 treatment (Treatment start date 14Apr2022 and Treatment stop date 18Apr2022). Patient received concomitant therapy with Generic (Unspecified manufacturer).
Vomiting, not breathing, hives, coughing deep bloody red color mucus.
Suspected Vaccination failure; Got the vaccine have had Shingles 3 times since; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows:  The age at vaccination was not reported.  The patient received Shingles vaccine and had Shingles 3 times since. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation for shingles infection and time to event onset were unknown.